[{"address1": "520 Applewood Crescent", "city": "Vaughan", "state": "ON", "zip": "L4K 4B4", "country": "Canada", "phone": "(905) 695-7700", "website": "https://www.bausch.com", "industry": "Medical Instruments & Supplies", "industryKey": "medical-instruments-supplies", "industryDisp": "Medical Instruments & Supplies", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.", "fullTimeEmployees": 13000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Brenton L.  Saunders J.D.", "age": 53, "title": "CEO & Chairman", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 10133558, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Osama A. Eldessouky", "age": 51, "title": "Executive VP & CFO", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 1319667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. A. Robert D. Bailey", "age": 60, "title": "Executive VP & Chief Legal Officer", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 1164897, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yehia  Hashad M.D.", "age": 55, "title": "Executive VP of Research & Development and Chief Medical officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 1225229, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Stewart", "age": 48, "title": "President of Global Pharmaceuticals & International Consumer", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 1369384, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alan  Waterhouse CPFA, MBA", "age": 63, "title": "Executive VP and Chief Supply Chain & Operations Officer", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Frederick J. Munsch", "age": 52, "title": "Senior VP, Controller & Chief Accounting Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathon L. Kellerman", "title": "Chief Compliance Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "T.J.  Crawford", "title": "Chief Communications Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Manisha A. Narasimhan Ph.D.", "age": 46, "title": "Chief Corporate Development & Digital Officer", "yearBorn": 1977, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 16.31, "open": 16.4, "dayLow": 15.89, "dayHigh": 16.34, "regularMarketPreviousClose": 16.31, "regularMarketOpen": 16.4, "regularMarketDayLow": 15.89, "regularMarketDayHigh": 16.34, "beta": 0.461, "forwardPE": 13.817392, "volume": 183668, "regularMarketVolume": 183668, "averageVolume": 578964, "averageVolume10days": 228110, "averageDailyVolume10Day": 228110, "bid": 15.92, "ask": 15.93, "bidSize": 800, "askSize": 800, "marketCap": 5591611904, "fiftyTwoWeekLow": 13.16, "fiftyTwoWeekHigh": 17.915, "priceToSalesTrailing12Months": 1.2439626, "fiftyDayAverage": 15.902, "twoHundredDayAverage": 15.47865, "currency": "USD", "enterpriseValue": 10162414592, "profitMargins": -0.10145, "floatShares": 40935993, "sharesOutstanding": 351895008, "sharesShort": 1905405, "sharesShortPriorMonth": 2061246, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.88505995, "heldPercentInstitutions": 0.117510006, "shortRatio": 1.83, "shortPercentOfFloat": 0.0464, "impliedSharesOutstanding": 353081984, "bookValue": 18.486, "priceToBook": 0.85956943, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -456000000, "trailingEps": -1.29, "forwardEps": 1.15, "pegRatio": 13.21, "enterpriseToRevenue": 2.261, "enterpriseToEbitda": 16.742, "52WeekChange": -0.05229515, "SandP52WeekChange": 0.24014747, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "BLCO", "underlyingSymbol": "BLCO", "shortName": "Bausch + Lomb Corporation", "longName": "Bausch + Lomb Corporation", "firstTradeDateEpochUtc": 1651843800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "2dfa4f41-10d0-3324-be8e-f99a01abce5b", "messageBoardId": "finmb_1678122959", "gmtOffSetMilliseconds": -14400000, "currentPrice": 15.89, "targetHighPrice": 27.09, "targetLowPrice": 27.09, "targetMeanPrice": 27.09, "targetMedianPrice": 27.09, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 285000000, "totalCashPerShare": 0.81, "ebitda": 607000000, "totalDebt": 4632000000, "quickRatio": 0.773, "currentRatio": 1.652, "totalRevenue": 4495000064, "debtToEquity": 70.395, "revenuePerShare": 12.803, "returnOnAssets": 0.00962, "returnOnEquity": -0.06495, "freeCashflow": -88875000, "operatingCashflow": 119000000, "revenueGrowth": 0.175, "grossMargins": 0.60845, "ebitdaMargins": 0.13504, "operatingMargins": 0.03043, "financialCurrency": "USD", "trailingPegRatio": 0.8878, "__fetch_time": "2024-09-05"}]